4

Back to all posts

Cryopreserved Liquid Amnion Product vs. Powder (Lyophilized) Amnion Product

Amniotic tissue contains naturally occurring elements such as growth factors, cytokines, extracellular matrix proteins, and exosomes. These components are intrinsic to the native structure of the amniotic membrane and fluid and may be beneficial in supporting tissue environments when properly preserved.

Cryopreservation is designed to maintain the original biological characteristics of the tissue by avoiding the drying and sterilization steps that can alter protein structure. In contrast, lyophilization may lead to degradation and reduced stability of sensitive biological components during the drying, rehydration, and sterilization processes. 1

 

Comparing Preservation Methods: Cryopreservation vs. Lyophilization

Characteristic Cryopreserved Amnion Lyophilized Amnion
End Form Liquid Powder
Preparation Thawing required Rehydration required
Storage Conditions Frozen Room temperature
Sterilization Not required May be required
Biological Component Retention Higher retention May be reduced
Protein Stability Preserves Stability Higher risk of denaturation

 

Clinical Context: Interpreting Publicly Available Data

In a publicly referenced clinical study evaluating micronized dehydrated human amnion chorion membrane (dHACM)—a type of lyophilized product—results showed no meaningful difference compared to saline at both 90 and 180 days when evaluating knee pain and function in patients with osteoarthritis. While outcomes can vary based on many factors, these findings emphasize the importance of preservation methods in maintaining biological value. 2

Renovo® does not claim specific clinical outcomes. However, it is processed to preserve the natural biological characteristics of equine amniotic tissue, consistent with its intended use to supplement and protect tissues.

 

Why Renovo® Uses Cryopreservation

Renovo® is an acellular, equine amniotic tissue allograft manufactured under Current Good Tissue Practice (cGTP) guidelines. It is cryopreserved to:

  • Help maintain biological consistency across batches
  • Eliminate the need for rehydration or additional sterilization
  • Provide a product that is consistent in composition and ready-to-use upon thawing

Renovo® is intended for equine use to supplement and protect tissues. It is not a stem cell product and contains no live cells. The formulation preserves a blend of biological components intrinsic to amniotic tissue.

 

Summary for Veterinary Professionals

  • Not all preservation methods are the same—biological consistency may vary depending on processing.
  • Cryopreserved amnion helps retain native protein and tissue structure.
  • Renovo® offers a cryopreserved, acellular allograft that is ready for use and supports tissue handling consistency.
  • Renovo® is labeled and marketed exclusively to supplement and protect tissues, without claims of therapeutic or clinical effect.

 

Want to Learn More?

Renovo® is intended solely to supplement and protect tissues. Any decisions regarding product usage should be made at the discretion of the veterinarian.

If you’d like to learn more or connect with a colleague who has experience using Renovo® in practice, we welcome you to fill out a contact form here.

 
 

 

1. Acta Ophthalmol  2009 Jun;87(4):396-403. Effects of Lyophilization on Human Amniotic Membrane

2. Study referencing clinical data at 90 and 180 days: https://clinicaltrials.gov/study/NCT03485157?term=mimedx&page=2&rank=11&tab=results

You may want to read these articles

RenoVō® CASE STUDY: Puncture Wound

RenoVō® CASE STUDY: Puncture Wound

Case presentation - June 9, 2022: A three-year-old Quarter Horse filly backed into the catch for the stall door and punctured herself, creating a large, deep wound on her left thigh. The wound was sutured with internal and external stiches at clinic, however the...

RenoVō® CASE STUDY: Superficial Digital Flexor Tendon (RH)

RenoVō® CASE STUDY: Superficial Digital Flexor Tendon (RH)

Case presentation - June 9, 2016: A 9 year old Warmblood jumping horse presented with a superficial digital flexor tendon injury of the right hind leg. The horse was treated with stem cell injections. After 10 months of rest and rehabilitation, the horse slowly went...